Stay updated on Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.5 to v3.6.6, indicating a minor template/backend update. No study content or data are changed.
    Difference
    0.1%
    Check dated 2026-08-30T15:46:22.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added to the page, indicating an updated version of the study record display. Older study-record items and documents (e.g., PDFs, past posting dates, and related links) were removed from the page.
    Difference
    17%
    Check dated 2026-08-09T00:16:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a software release. There are no visible changes to the study content or page functionality beyond the metadata.
    Difference
    0.1%
    Check dated 2026-07-25T17:14:48.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new revision tag v3.6.3 replaced v3.6.2 on the page. This indicates a small update to the page template or content management.
    Difference
    0.1%
    Check dated 2026-07-04T13:26:55.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.0 to v3.6.2, indicating a minor backend/UI update. This change does not alter the study details or their presentation to users.
    Difference
    0.1%
    Check dated 2026-06-27T05:51:29.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    The page now indicates no participants are being sought and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment label formatting and changes the release note from Revision: v3.5.5 to Revision: v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:39:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.